167 related articles for article (PubMed ID: 14552705)
1. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control.
Ramsay RG; Ciznadija D; Vanevski M; Mantamadiotis T
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):59-67. PubMed ID: 14552705
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB.
Ramsay RG; Friend A; Vizantios Y; Freeman R; Sicurella C; Hammett F; Armes J; Venter D
Cancer Res; 2000 Apr; 60(7):1805-9. PubMed ID: 10766162
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
Chun KS; Surh YJ
Biochem Pharmacol; 2004 Sep; 68(6):1089-100. PubMed ID: 15313405
[TBL] [Abstract][Full Text] [Related]
4. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors.
Iñiguez MA; Punzón C; Fresno M
J Immunol; 1999 Jul; 163(1):111-9. PubMed ID: 10384106
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
[TBL] [Abstract][Full Text] [Related]
7. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
8. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
9. Is cyclooxygenase-2 important in skin carcinogenesis?
Fischer SM
J Environ Pathol Toxicol Oncol; 2002; 21(2):183-91. PubMed ID: 12086405
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
11. [Biological functions of cyclooxygenase 2: control of its expression and activity].
Jacquemin C
J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2.
Gierse JK; Staten NR; Casperson GF; Koboldt CM; Trigg JS; Reitz BA; Pierce JL; Seibert K
Vet Ther; 2002; 3(3):270-80. PubMed ID: 12447834
[TBL] [Abstract][Full Text] [Related]
13. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
14. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
16. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
Bottone FG; Martinez JM; Alston-Mills B; Eling TE
Carcinogenesis; 2004 Mar; 25(3):349-57. PubMed ID: 14633654
[TBL] [Abstract][Full Text] [Related]
17. Cyclo-oxygenase 2 inhibitors: emerging roles in the gut.
Grover JK; Yadav S; Vats V; Joshi YK
Int J Colorectal Dis; 2003 Jul; 18(4):279-91. PubMed ID: 12774242
[TBL] [Abstract][Full Text] [Related]
18. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved.
Hou DX; Yanagita T; Uto T; Masuzaki S; Fujii M
Biochem Pharmacol; 2005 Aug; 70(3):417-25. PubMed ID: 15963474
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts.
Mifflin RC; Saada JI; Di Mari JF; Valentich JD; Adegboyega PA; Powell DW
Mol Pharmacol; 2004 Feb; 65(2):470-8. PubMed ID: 14742690
[TBL] [Abstract][Full Text] [Related]
20. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]